Claudia Bartolini
Overview
Explore the profile of Claudia Bartolini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, et al.
Pharmaceuticals (Basel)
. 2023 Mar;
16(3).
PMID: 36986565
This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective....
12.
Holthuis E, Smits E, Spentzouris G, Beier D, Enders D, Gini R, et al.
Drugs Real World Outcomes
. 2022 Jul;
9(4):597-607.
PMID: 35790603
Background: A high degree of adherence to direct oral anticoagulants is essential for reducing the risk of ischaemic stroke and systemic embolism in patients with atrial fibrillation, owing to the...
13.
Roberto G, Girardi A, Barone-Adesi F, Pecere A, Ientile V, Bartolini C, et al.
Front Pharmacol
. 2022 Jun;
13:871052.
PMID: 35707398
To verify whether, in patients on metformin (MET) monotherapy for type 2 diabetes (T2D), the add-on of a dipeptidyl peptidase inhibitor (DPP4i) compared to a sulfonylurea (SU) can delay the...
14.
Sultana J, Crisafulli S, Almas M, Antonazzo I, Baan E, Bartolini C, et al.
Pharmacoepidemiol Drug Saf
. 2022 Jan;
31(6):689-705.
PMID: 35092329
Background: The European post-authorisation study (EU PAS) register is a repository launched in 2010 by the European Medicines Agency (EMA). All EMA-requested PAS, commonly observational studies, must be recorded in...
15.
Smits E, Andreotti F, Houben E, Crijns H, Haas S, Spentzouris G, et al.
Drugs Real World Outcomes
. 2022 Jan;
9(2):199-209.
PMID: 34993898
Background: Direct oral anticoagulants are available for patients with atrial fibrillation. Objective: This study compared adherence and persistence of once-daily (QD) vs twice-daily (BID) direct oral anticoagulants in patients with...
16.
Convertino I, Giometto S, Gini R, Cazzato M, Fornili M, Valdiserra G, et al.
J Clin Med
. 2021 Dec;
10(24).
PMID: 34945038
Scanty information on clustering longitudinal real-world data is available in the medical literature about the adherence implementation phase in rheumatoid arthritis (RA). To identify and characterize trajectories by analyzing the...
17.
Thurin N, Pajouheshnia R, Roberto G, Dodd C, Hyeraci G, Bartolini C, et al.
Clin Pharmacol Ther
. 2021 Nov;
111(1):321-331.
PMID: 34826340
In 2019, the Innovative Medicines Initiative (IMI) funded the ConcePTION project-Building an ecosystem for better monitoring and communicating safety of medicines use in pregnancy and breastfeeding: validated and regulatory endorsed...
18.
Convertino I, Cazzato M, Giometto S, Gini R, Valdiserra G, Cappello E, et al.
Sci Rep
. 2021 Oct;
11(1):20314.
PMID: 34645838
Validation of algorithms for selecting patients from healthcare administrative databases (HAD) is recommended. This PATHFINDER study section is aimed at testing algorithms to select rheumatoid arthritis (RA) patients from Tuscan...
19.
Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifiro G, Kirchmayer U, et al.
Vaccines (Basel)
. 2021 Aug;
9(7).
PMID: 34358133
To investigate the association of the 2019-2020 influenza vaccine with prognosis of patients positive for SARS-CoV-2A, a large multi-database cohort study was conducted in four Italian regions (i.e., Lazio, Lombardy,...
20.
Spini A, Hyeraci G, Bartolini C, Donnini S, Rosellini P, Gini R, et al.
Int J Environ Res Public Health
. 2021 Jul;
18(14).
PMID: 34300130
Routinely collected electronic healthcare data (rcEHD) have a tremendous potential for enriching pre-marketing evidence on target- and immunotherapies used to treat lung cancer (LC). A scoping review was performed to...